Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ZY

Zymergen (ZY) Stock Price, News & Analysis

Zymergen logo

About Zymergen Stock (NASDAQ:ZY)

Key Stats

Today's Range
$2.43
$2.43
50-Day Range
$2.35
$3.14
52-Week Range
$1.10
$12.42
Volume
85 shs
Average Volume
1.23 million shs
Market Capitalization
$253.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Receive ZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter.

ZY Stock News Headlines

Nvidia’s world of pain awaits
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Ginkgo Bioworks: Broken Narrative
See More Headlines

ZY Stock Analysis - Frequently Asked Questions

Zymergen (ZY) raised $401 million in an initial public offering on Thursday, April 22nd 2021. The company issued 13,600,000 shares at a price of $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zymergen investors own include Tesla (TSLA), Palantir Technologies (PLTR), NIO (NIO), Meta Platforms (META), PayPal (PYPL), Snowflake (SNOW) and Teladoc Health (TDOC).

Company Calendar

Today
11/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Fax
N/A
Employees
502
Year Founded
N/A

Profitability

Net Income
$-361,790,000.00
Net Margins
-2,508.94%
Pretax Margin
-2,508.42%

Debt

Sales & Book Value

Annual Sales
$16.74 million
Book Value
$3.99 per share

Miscellaneous

Free Float
92,145,000
Market Cap
$253.58 million
Optionable
Not Optionable
Beta
1.69
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:ZY) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners